FGF14 Gene Spinocerebellar Ataxia Type 27 Autosomal Dominant Genetic Test sale cost 4400 AED
SMN1 Gene Spinal Muscular Atrophy Type 3 Genetic Test sale cost 4400 AED SMN1 Gene Spinal Muscular Atrophy Type 3 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
TDP1 Gene Spinocerebellar Ataxia with Axonal Neuropathy Autosomal Recessive Genetic Test sale cost 4400 AED TDP1 Gene Spinocerebellar Ataxia with Axonal Neuropathy Autosomal Recessive Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

FGF14 Gene Spinocerebellar Ataxia Type 27 Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FGF14 gene, associated with Spinocerebellar Ataxia Type 27 (SCA27), is a critical area of genetic study due to its implications in the development of this specific type of ataxia. Spinocerebellar ataxia is a progressive, neurodegenerative condition characterized by coordination and balance difficulties, stemming from the cerebellum’s degeneration. SCA27, in particular, is distinguished by its genetic link to mutations in the FGF14 gene, which plays a significant role in the functioning of neurons in the cerebellum.

Recognizing the importance of early diagnosis and the potential for family planning and management, DNA Labs UAE offers a specialized genetic test targeting the FGF14 gene to identify mutations associated with Spinocerebellar Ataxia Type 27. This test is vital for individuals with a family history of SCA27 or those exhibiting symptoms suggestive of spinocerebellar ataxias.

The testing process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the FGF14 gene that are known to cause SCA27. This autosomal dominant condition means a single copy of the altered gene in each cell is sufficient to cause the disorder, making the identification of such mutations critical for affected families.

The cost of the FGF14 gene test for Spinocerebellar Ataxia Type 27 at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated techniques used to detect genetic variations accurately, and the expertise required to interpret the results. Given the complexity of genetic testing and the potential implications of the results, genetic counseling is often recommended alongside testing to provide individuals and families with the support and information needed to understand their risk and options moving forward.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FGF14 Gene Spinocerebellar Ataxia Type 27 Autosomal Dominant Genetic Test

Cost: AED 4400.0

Overview

Spinocerebellar ataxia type 27 (SCA27) is a rare genetic disorder characterized by progressive degeneration of the cerebellum and other areas of the brain. It is caused by mutations in the FGF14 gene. The FGF14 gene provides instructions for making a protein called fibroblast growth factor 14, which is involved in the development and function of neurons in the brain, particularly in the cerebellum. Mutations in the FGF14 gene disrupt the normal function of the protein, leading to the signs and symptoms of SCA27.

Test Details

The FGF14 Gene Spinocerebellar Ataxia Type 27 Autosomal Dominant Genetic Test is a neurogenetic test offered by DNA Labs UAE. The test utilizes NGS (Next-Generation Sequencing) technology to analyze multiple genes simultaneously and identify mutations or variations in the DNA sequence. In the case of SCA27, this test specifically detects mutations in the FGF14 gene.

Components

  • Test Name: FGF14 Gene Spinocerebellar Ataxia Type 27 Autosomal Dominant Genetic Test
  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the FGF14 Gene Spinocerebellar Ataxia Type 27 Autosomal Dominant Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with SCA27. This information helps in the interpretation of test results and provides valuable insights for genetic counseling and guidance.

Inheritance

Autosomal dominant inheritance means that a person only needs to inherit one copy of the mutated gene from either parent to develop the disorder. If a person has a parent with SCA27, they have a 50% chance of inheriting the mutated gene and developing the condition.

Genetic Counseling

It is important to note that genetic testing for SCA27 should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate genetic counseling and guidance. They can help individuals understand the implications of the test results, provide support, and assist in making informed decisions regarding medical management and family planning.

At DNA Labs UAE, we strive to provide accurate and reliable genetic testing services. Our FGF14 Gene Spinocerebellar Ataxia Type 27 Autosomal Dominant Genetic Test can help confirm a diagnosis of SCA27 in individuals with symptoms suggestive of the condition and also identify carriers of the mutated gene within a family. Contact us today to learn more about this test and how it can benefit you and your loved ones.

Test Name FGF14 Gene Spinocerebellar ataxia type 27 autosomal dominant Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for FGF14 Gene Spinocerebellar ataxia type 27, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with FGF14 Gene Spinocerebellar ataxia type 27, autosomal dominant
Test Details

Spinocerebellar ataxia type 27 (SCA27) is a rare genetic disorder characterized by progressive degeneration of the cerebellum and other areas of the brain. It is caused by mutations in the FGF14 gene.

The FGF14 gene provides instructions for making a protein called fibroblast growth factor 14. This protein is involved in the development and function of neurons in the brain, particularly in the cerebellum. Mutations in the FGF14 gene disrupt the normal function of the protein, leading to the signs and symptoms of SCA27.

Autosomal dominant inheritance means that a person only needs to inherit one copy of the mutated gene from either parent to develop the disorder. If a person has a parent with SCA27, they have a 50% chance of inheriting the mutated gene and developing the condition.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify mutations or variations in the DNA sequence. In the case of SCA27, NGS genetic testing can be used to detect mutations in the FGF14 gene. This test can help confirm a diagnosis of SCA27 in individuals with symptoms suggestive of the condition and also identify carriers of the mutated gene within a family.

It is important to note that genetic testing for SCA27 should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate genetic counseling and guidance.

SKU: TEST-2069 Category:

Related products